KOSDAQ · Healthcare · ₩84B
₩4,980-11.39%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 0.4% · as of 26.10.27
Among 97 제약 peers
Quarterly Revenue Growth
“신약 성장 기반은 갖췄고 본업 수익성 회복을 봐야 해요.”
In the company's words · 2026 2분기 filing